eTheRNA immunotherapies clinical trials
Acquired by Valerio Therapeutics
The registry lists 1 studies whose lead sponsor is eTheRNA immunotherapies. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 21, 2021.
Registry sponsor names on this page
- eTheRNA immunotherapies1 study
Something wrong with this grouping? Tell us on the Valerio Therapeutics page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Valerio Therapeutics studies →
- Safety of Intranodal ECI-006 in Melanoma PatientsTerminatedNCT03394937Phase 1
Sponsor listed in the registry: eTheRNA immunotherapies · eTheRNA immunotherapies — acquired company within the Valerio Therapeutics group